# Automated Breast Ultrasound System Market > Automated Breast Ultrasound System Market Research Report By Product Type (2D Automated Breast Ultrasound System, 3D Automated Breast Ultrasound System), By Application (Breast Cancer Screening, Diagnostic Imaging for Breast Cancer, Follow-up Imaging for Breast Cancer), By End User (Hospitals and Clinics, Diagnostic Imaging Centers, Research Institutions, Others), By Technology (Conventional Ultrasound, Shear Wave Elastography, Contrast-Enhanced Ultrasound, Others) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.28% - **2024:** $ 3.46 Billion - **2025:** $ 3.68 Billion - **2035:** $ 6.76 Billion - **Key Players:** GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Hologic (US), Fujifilm (JP), Mindray (CN), Esaote (IT), Samsung Medison (KR) **Report ID:** MRFR/HC/39384-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/automated-breast-ultrasound-system-market-28877 --- ## Market Summary ## **Automated Breast Ultrasound System Market Overview** As per MRFR analysis, the Automated Breast Ultrasound System Market Size was estimated at 3.46 (USD Billion) in 2024. The Automated Breast Ultrasound System Market Industry is expected to grow from 3.67 (USD Billion) in 2025 to 6.36 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 6.28% during the forecast period (2025 - 2034). ### **Key Automated Breast Ultrasound System Market Trends Highlighted** The Automated Breast Ultrasound (ABUS) system market is witnessing a surge in demand due to its advantages over traditional breast imaging techniques. Key drivers of this growth include the rising incidence of breast cancer, increasing awareness and adoption of early detection measures, and the need for more precise and sensitive breast imaging solutions. The market is further fueled by technological advancements such as 3D and 4D ABUS, which provide more detailed and comprehensive breast imaging. Additionally, the growing focus on personalized and tailored healthcare is driving demand for ABUS systems that can offer individualized breast imaging and monitoring plans. The evolving healthcare landscape, with an emphasis on minimally invasive and cost-effective procedures, is creating opportunities for ABUS systems to play a pivotal role in breast cancer detection and management. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Automated Breast Ultrasound System Market Drivers** ### Increasing Prevalence of Breast Cancer Breast cancer is the most common type of cancer among women worldwide, with an estimated 2.3 million new cases diagnosed in 2020. The increasing prevalence of [breast cancer](../../../reports/global-breast-cancer-market-1379) is a major driver of the automated breast ultrasound system market. Automated breast ultrasound systems provide a more accurate and efficient way to detect and diagnose breast cancer, which can lead to earlier treatment and better outcomes for patients. In addition, automated breast ultrasound systems are less invasive and more comfortable for patients than traditional breast biopsies, which can further increase their adoption. ### Technological Advancements Technological advancements are another major driver of the automated breast ultrasound system market. Automated breast ultrasound systems are becoming increasingly sophisticated and accurate, which is making them more effective in detecting and diagnosing breast cancer. For example, some automated breast ultrasound systems now use artificial intelligence (AI) to help identify suspicious lesions and tumors. AI-powered automated breast ultrasound systems can improve the accuracy of breast cancer detection and reduce the need for unnecessary biopsies. ### Growing Awareness of Breast Cancer Screening Growing awareness of breast cancer screening is also driving the automated breast ultrasound system market. More and more women are becoming aware of the importance of regular breast cancer screening, and this is leading to an increase in the demand for automated breast ultrasound systems. Automated breast ultrasound systems are a convenient and effective way to screen for breast cancer, and they can help to detect cancer at an early stage, when it is most treatable ## **Automated Breast Ultrasound System Market Segment Insights** ### **Automated Breast Ultrasound System Market Product Type Insights** The Automated Breast Ultrasound System Market is segmented based on product type into 2D Automated Breast Ultrasound System and 3D Automated Breast Ultrasound System. The 2D Automated Breast Ultrasound System segment accounted for a larger revenue share in 2023 and is expected to maintain its dominance throughout the forecast period. The growth of this segment can be attributed to the widespread adoption of 2D Automated Breast Ultrasound Systems in screening programs for breast cancer detection. These systems provide high-quality images that allow radiologists to visualize breast tissue more clearly, leading to improved detection and characterization of breast lesions. The 3D Automated Breast Ultrasound System segment is expected to witness significant growth during the forecast period. The increasing adoption of 3D Automated Breast Ultrasound Systems in diagnostic and interventional procedures is driving the growth of this segment. 3D Automated Breast Ultrasound Systems offer several advantages over 2D systems, including improved visualization of breast anatomy, better detection of small lesions, and more accurate guidance for biopsies. The Automated Breast Ultrasound System Market is expected to grow significantly in the coming years, driven by the rising incidence of breast cancer, increasing awareness about breast cancer screening, and technological advancements in Automated Breast Ultrasound Systems. The market growth is also supported by the growing demand for non-invasive and radiation-free breast imaging techniques. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Automated Breast Ultrasound System Market Application Insights** The Automated Breast Ultrasound System Market is segmented into Breast Cancer Screening, Diagnostic Imaging for Breast Cancer, and Follow-up Imaging for Breast Cancer. Breast Cancer Screening is the largest segment, accounting for over 45% of the Automated Breast Ultrasound System Market revenue in 2023. Diagnostic Imaging for Breast Cancer is the second largest segment, with a market share of over 30%. Follow-up Imaging for Breast Cancer is the smallest segment, with a market share of less than 25%. The Breast Cancer Screening segment is expected to continue to dominate the market over the forecast period, with a CAGR of over 5%. The Diagnostic Imaging for Breast Cancer segment is expected to grow at a CAGR of over 4%, while the Follow-up Imaging for Breast Cancer segment is expected to grow at a CAGR of over 3%. The growth of the Automated Breast Ultrasound System Market is attributed to the increasing incidence of breast cancer, the rising demand for accurate and non-invasive diagnostic tools, and the technological advancements in automated breast ultrasound systems. ### **Automated Breast Ultrasound System Market End User Insights** The Automated Breast Ultrasound System Market segmentation by End User comprises Hospitals and Clinics, Diagnostic Imaging Centers, Research Institutions, and Others. Hospitals and Clinics held the dominant market share in 2023 and are projected to continue their dominance during the forecast period. The high adoption of automated breast ultrasound systems in hospitals and clinics can be attributed to the increasing number of breast cancer cases, growing awareness about early detection, and technological advancements in ultrasound imaging. Diagnostic Imaging Centers account for a significant market share and are expected to grow steadily due to the increasing demand for specialized breast imaging services. Research Institutions are also expected to contribute to the growth of the market as they play a crucial role in developing and evaluating new automated breast ultrasound technologies. The 'Others' segment includes private clinics, ambulatory surgical centers, and mobile breast screening units, which are anticipated to witness moderate growth during the forecast period. ### **Automated Breast Ultrasound System Market Technology Insights** The Automated Breast Ultrasound System Market is segmented by Technology into Conventional Ultrasound, Shear Wave Elastography, Contrast-Enhanced Ultrasound, and Others. Conventional Ultrasound was the most commonly used technology in Automated Breast Ultrasound Systems, accounting for over 50% of the global market revenue in 2023. It is a non-invasive imaging technique that uses high-frequency sound waves to create images of the breast tissue. Shear Wave Elastography is a newer technology that is gaining popularity due to its ability to measure the stiffness of breast tissue. Contrast-Enhanced Ultrasound uses a contrast agent to enhance the visibility of blood vessels in the breast tissue, which can help to identify tumors. Others include emerging technologies such as 3D ultrasound and tomosynthesis, which are expected to gain market share in the coming years. ### **Automated Breast Ultrasound System Market Regional Insights** The regional segmentation of the Automated Breast Ultrasound System Market offers insights into the geographical distribution of market revenues. North America dominates the market with a significant share, driven by factors such as advanced healthcare infrastructure, high awareness about breast cancer screening, and reimbursement policies favoring the adoption of automated breast ultrasound systems. Europe follows suit, with a sizable market share attributed to government initiatives promoting early cancer detection and technological advancements in the healthcare sector. The APAC region is projected to witness substantial growth in the coming years, owing to rising disposable incomes, increasing prevalence of breast cancer, and expanding healthcare access in emerging economies like China and India. South America and MEA represent emerging markets with untapped growth potential, driven by growing healthcare expenditure and increasing awareness about breast cancer screening. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Automated Breast Ultrasound System Market Key Players and Competitive Insights** Major players in the Automated Breast Ultrasound System Market are continuously developing innovative technologies and products to gain a competitive edge. They are also focusing on strategic partnerships and acquisitions to expand their market reach. Leading Automated Breast Ultrasound System Market players are investing heavily in research and development to enhance their product offerings and meet the evolving needs of customers. The Automated Breast Ultrasound System Market development is driven by technological advancements, increasing demand for early detection of breast cancer, and government initiatives to promote breast cancer screening. The competitive landscape is expected to remain dynamic, with new entrants and established players vying for market share. GE Healthcare, a leading player in the Automated Breast Ultrasound System Market, offers advanced automated breast ultrasound systems that provide high-quality images and efficient workflow. The company's Invenia Automated Breast Ultrasound System is designed to enhance breast cancer detection and reduce operator dependency. GE Healthcare also focuses on providing comprehensive training and support to healthcare professionals to ensure optimal utilization of its systems. Siemens Healthineers, a competitor in the Automated Breast Ultrasound System Market, provides a range of automated breast ultrasound solutions. The company's ACUSON S2000 Automated Breast Ultrasound System features AI-powered image processing and advanced transducer technology for improved image quality and diagnostic accuracy. Siemens Healthineers also offers cloud-based data management and analysis tools to support remote collaboration and efficient patient management. ### **Key Companies in the Automated Breast Ultrasound System Market Include** - [GE Healthcare](https://www.gehealthcare.com/products/ultrasound/breast-ultrasound?srsltid=AfmBOopw5Yizj80Bb_44eQuJDJmUyIjJPadK-6LrSukYXACbn9MhIn86) - XEROX - Siemens Healthineers - Carestream Health - Acuson - FUJIFILM Holdings - Koninklijke Philips - Analogic Corporation - SonoScape Medical - Mindray - Toshiba Medical Systems - Hitachi Medical - Hologic - Samsung Medison - Esaote ## Automated Breast Ultrasound System Market Industry Developments - **Q3 2025: In July 2025, GE HealthCare launched its Invenia ABUS 3.0 with enhanced AI lesion detection and faster scan times.** GE HealthCare introduced the Invenia ABUS 3.0 automated breast ultrasound system, featuring advanced AI for lesion detection and improved workflow efficiency, targeting supplemental screening for women with dense breast tissue. - **Q2 2025: In June 2025, Siemens Healthineers received CE Mark approval for its Acuson ABUS Elite system.** Siemens Healthineers secured CE Mark for its Acuson ABUS Elite, a 3D volumetric imaging system with automated positioning, enabling commercial rollout in European markets. ## **Automated Breast Ultrasound System Market Segmentation Insights** ### **Automated Breast Ultrasound System Market Product Type Outlook** - 2D Automated Breast Ultrasound System - 3D Automated Breast Ultrasound System ### **Automated Breast Ultrasound System Market Application Outlook** - Breast Cancer Screening - Diagnostic Imaging for Breast Cancer - Follow-up Imaging for Breast Cancer ### **Automated Breast Ultrasound System Market End User Outlook** - Hospitals and Clinics - Diagnostic Imaging Centers - Research Institutions - Others ### **Automated Breast Ultrasound System Market Technology Outlook** - Conventional Ultrasound - Shear Wave Elastography - Contrast-Enhanced Ultrasound - Others ### **Automated Breast Ultrasound System Market Regional Outlook** - North America - Europe - South America - Asia Pacific - Middle East and Africa ## Market Drivers ### Regulatory Support and Guidelines The Automated Breast Ultrasound System Market is bolstered by supportive regulatory frameworks and guidelines that promote the use of advanced imaging technologies. Regulatory bodies are increasingly recognizing the efficacy of automated breast ultrasound systems in enhancing screening processes. This support is evident in the approval of new devices and the establishment of guidelines that encourage their integration into routine breast cancer screening protocols. As healthcare providers align with these regulations, the market is likely to expand, with an anticipated growth rate of 7% annually through 2025. The emphasis on regulatory compliance ensures that the Automated Breast Ultrasound System Market remains competitive and innovative, ultimately benefiting patient care. ### Rising Incidence of Breast Cancer The increasing incidence of breast cancer worldwide is a primary driver for the Automated Breast Ultrasound System Market. As statistics indicate a rise in breast cancer cases, the demand for effective screening tools becomes more pronounced. Automated breast ultrasound systems offer a non-invasive and efficient method for detecting tumors, particularly in women with dense breast tissue. This growing need for reliable screening solutions is expected to propel market growth, with projections suggesting a market size of USD 1.2 billion by 2025. The Automated Breast Ultrasound System Market is thus positioned to play a crucial role in addressing the challenges posed by rising breast cancer rates, ensuring timely diagnosis and treatment. ### Technological Advancements in Imaging The Automated Breast Ultrasound System Market is experiencing a surge in technological advancements that enhance imaging capabilities. Innovations such as 3D imaging and artificial intelligence integration are improving diagnostic accuracy and efficiency. These advancements allow for better detection of breast abnormalities, which is crucial for early intervention. The market is projected to grow as healthcare providers increasingly adopt these technologies to improve patient outcomes. In 2025, the market is expected to reach a valuation of approximately USD 1.5 billion, driven by the demand for more precise imaging solutions. As technology continues to evolve, the Automated Breast Ultrasound System Market is likely to see further enhancements that could redefine breast cancer screening protocols. ### Integration with Other Diagnostic Modalities The trend towards integrating automated breast ultrasound systems with other diagnostic modalities is shaping the Automated Breast Ultrasound System Market. This integration allows for a more comprehensive approach to breast cancer screening and diagnosis, combining ultrasound with mammography and MRI. Such multimodal strategies enhance diagnostic accuracy and provide healthcare professionals with a more complete picture of breast health. As healthcare facilities seek to improve patient outcomes through advanced diagnostic techniques, the market is likely to see increased adoption of integrated systems. By 2025, the Automated Breast Ultrasound System Market could experience a growth rate of 6%, driven by the demand for holistic diagnostic solutions that cater to diverse patient needs. ### Increased Awareness and Screening Initiatives Rising awareness regarding breast cancer and the importance of early detection is significantly impacting the Automated Breast Ultrasound System Market. Educational campaigns and community outreach programs are encouraging women to undergo regular screenings. This heightened awareness is leading to an increase in the number of women opting for breast ultrasound examinations, particularly in high-risk populations. As a result, the market is witnessing a steady growth trajectory, with an estimated increase in demand for automated systems. By 2025, the market could see a compound annual growth rate (CAGR) of around 8%, reflecting the growing emphasis on proactive health measures. The Automated Breast Ultrasound System Market is thus positioned to benefit from this trend as more healthcare facilities adopt these systems to meet rising patient needs. ## Future Outlook The Automated Breast Ultrasound System Market is projected to grow at a 6.28% CAGR from 2025 to 2035, driven by technological advancements, increasing breast cancer awareness, and rising healthcare expenditures. **New opportunities:** - Development of AI-driven diagnostic tools for enhanced imaging accuracy. Expansion into emerging markets with tailored pricing strategies. Partnerships with healthcare providers for integrated breast health solutions. By 2035, the market is expected to achieve substantial growth, solidifying its role in breast cancer detection. ## Segment Insights ### By Product Type: 2D Automated Breast Ultrasound System (Largest) vs. 3D Automated Breast Ultrasound System (Fastest-Growing) The Automated Breast Ultrasound System market exhibits a distinct split between 2D and 3D product types, with 2D systems commanding the largest market share. This segment has long been favored due to its established technology and reliability in breast imaging. Conversely, the 3D Automated Breast Ultrasound Systems are gaining traction, appealing to healthcare providers seeking advanced diagnostic capabilities. As awareness of the benefits of more comprehensive imaging techniques grows, a steady shift in market dynamics is anticipated. Product Type: 2D Automated Breast Ultrasound System (Dominant) vs. 3D Automated Breast Ultrasound System (Emerging) The 2D Automated Breast Ultrasound System remains the dominant player in the market, known for its simplicity and effectiveness in breast cancer screenings. Its established presence means that many healthcare professionals prefer it for routine examinations, resulting in a strong user base. On the other hand, the 3D Automated Breast Ultrasound System, although emerging, is quickly capturing attention due to its enhanced imaging capabilities, which offer more nuanced views of breast tissue. These advanced systems can detect abnormalities that may be missed by their 2D counterparts, making them increasingly valuable in precision medicine and personalized healthcare approaches. ### By Application: Breast Cancer Screening (Largest) vs. Diagnostic Imaging for Breast Cancer (Fastest-Growing) In the Automated Breast Ultrasound System Market, the application segments display a varied distribution of market share. Breast Cancer Screening remains the largest segment, driven by increasing awareness about breast health and the critical need for early detection of breast cancer. This has led to a higher demand for automated solutions that can facilitate efficient and accurate screening processes. On the other hand, Diagnostic Imaging for Breast Cancer is witnessing rapid growth, fueled by technological advancements and an increase in breast cancer cases, highlighting the importance of precise imaging capabilities in diagnostics. Breast Cancer Screening (Dominant) vs. Follow-up Imaging for Breast Cancer (Emerging) Breast Cancer Screening holds a dominant position in the market due to its essential role in preventive healthcare. This application not only provides early detection but is also becoming more integrated with digital health technologies, enhancing the efficiency of screening processes. In contrast, Follow-up Imaging for Breast Cancer is an emerging segment that focuses on monitoring and assessing tumor responses post-treatment. It benefits from innovations in imaging technology and patient management systems, making follow-up processes more streamlined and effective. The increasing emphasis on holistic patient care and imaging accuracy underpins the growth potential of the follow-up imaging segment. ### By End User: Hospitals and Clinics (Largest) vs. Diagnostic Imaging Centers (Fastest-Growing) In the Automated Breast Ultrasound System Market, the distribution of market share among end users reveals that hospitals and clinics hold the largest share, playing a crucial role in the overall adoption of these systems. This segment benefits from the integration of advanced technologies into routine medical practices, which has become essential for enhanced patient care and early breast cancer detection. Conversely, diagnostic imaging centers are emerging as the fastest-growing segment, reflecting a shift towards specialized imaging services that cater to diverse patient needs and preferences. Hospitals and Clinics (Dominant) vs. Diagnostic Imaging Centers (Emerging) Hospitals and clinics represent the dominant end-user segment in the Automated Breast Ultrasound System Market due to their ability to invest in advanced diagnostic tools that improve patient outcomes. These facilities often have the capital and infrastructure necessary for adopting state-of-the-art technology, which positions them at the forefront of [breast imaging](https://www.marketresearchfuture.com/reports/breast-imaging-market-5612) services. On the other hand, diagnostic imaging centers are considered an emerging segment; they specialize in imaging procedures and are increasingly recognized for their efficiency and focus on patient-centric care. The rise of these centers is driven by a greater demand for outpatient services and the need for timely diagnosis, leading to their rapid growth in the market. ### By Technology: Conventional Ultrasound (Largest) vs. Shear Wave Elastography (Fastest-Growing) In the Automated Breast Ultrasound System Market, Conventional Ultrasound holds the largest share, recognized for its extensive application and established presence in medical diagnostics. It serves as the primary technology for many healthcare providers, owing to its reliability and cost-effectiveness. Shear Wave Elastography, while newer, is rapidly gaining traction for its ability to provide quantitative measurement of tissue stiffness, offering a promising alternative to conventional methods and helping to enhance diagnostic accuracy. Technology: Conventional Ultrasound (Dominant) vs. Shear Wave Elastography (Emerging) Conventional Ultrasound has long been the dominant force within the Automated Breast Ultrasound System Market, widely preferred by practitioners for its simplicity and effectiveness in visualizing breast tissue. Its comprehensive imaging capabilities make it a cornerstone of breast cancer screening and diagnosis. In contrast, Shear Wave Elastography is emerging as a progressive technology, transforming breast assessments through its innovative approach to evaluating tissue elasticity. This technique not only aids in differentiation between benign and malignant lesions but is also becoming increasingly integrated into routine screening protocols, reflecting a shift towards more sophisticated diagnostic methodologies. ## Regional Market Share Analysis ### North America : Leading Innovation and Adoption North America is the largest market for Automated Breast Ultrasound Systems, holding approximately 45% of the global market share. The region's growth is driven by increasing awareness of breast cancer, advancements in technology, and supportive government regulations. The FDA's approval of innovative devices has further catalyzed market expansion, leading to a surge in demand for early detection solutions. The United States is the primary contributor to this market, with significant investments from key players like GE Healthcare and Hologic. Canada also plays a vital role, focusing on enhancing healthcare infrastructure. The competitive landscape is characterized by a mix of established companies and emerging startups, all striving to innovate and improve patient outcomes. The presence of major players ensures a robust supply chain and continuous advancements in technology. ### Europe : Regulatory Support and Growth Europe is the second-largest market for Automated Breast Ultrasound Systems, accounting for around 30% of the global share. The region benefits from stringent regulations and guidelines that promote the adoption of advanced medical technologies. The European Medicines Agency (EMA) has been instrumental in ensuring that innovative solutions meet safety and efficacy standards, thereby boosting consumer confidence and market growth. Leading countries in this region include Germany, France, and the UK, where healthcare systems are increasingly integrating automated ultrasound technologies. Major players like Siemens Healthineers and Philips Healthcare are actively involved in research and development, enhancing their product offerings. The competitive landscape is robust, with a focus on collaboration between manufacturers and healthcare providers to improve diagnostic accuracy and patient care. ### Asia-Pacific : Rapid Growth and Adoption Asia-Pacific is witnessing rapid growth in the Automated Breast Ultrasound System Market, holding approximately 20% of the global share. The increasing prevalence of breast cancer and rising healthcare expenditure are key drivers of this growth. Countries like China and India are investing heavily in healthcare infrastructure, which is expected to further boost the demand for advanced diagnostic tools. Regulatory bodies are also becoming more supportive, facilitating quicker approvals for innovative technologies. China is the largest market in this region, with significant contributions from local manufacturers like Mindray. Japan and South Korea are also notable players, focusing on technological advancements and quality improvements. The competitive landscape is evolving, with both domestic and international companies vying for market share, leading to a dynamic environment for innovation and collaboration. ### Middle East and Africa : Emerging Market with Potential The Middle East and Africa region is gradually emerging in the Automated Breast Ultrasound System Market, accounting for about 5% of the global share. The growth is primarily driven by increasing awareness of breast cancer and the need for advanced diagnostic solutions. Governments in countries like the UAE and South Africa are investing in healthcare infrastructure, which is expected to enhance the adoption of automated ultrasound technologies. Key players in this region include local distributors and international companies looking to expand their footprint. The competitive landscape is characterized by a mix of established firms and new entrants, all aiming to address the growing demand for effective breast cancer screening solutions. Collaborative efforts between governments and private sectors are crucial for fostering innovation and improving healthcare access. .webp ## Competitive Benchmarking The Automated Breast Ultrasound System Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and an increasing emphasis on early breast cancer detection. Key players such as GE Healthcare (US), Siemens Healthineers (DE), and Hologic (US) are at the forefront, each adopting distinct strategies to enhance their market presence. GE Healthcare (US) focuses on innovation through the development of advanced imaging technologies, while Siemens Healthineers (DE) emphasizes partnerships with healthcare providers to expand its reach. Hologic (US) is strategically positioned through its commitment to research and development, aiming to introduce cutting-edge solutions that cater to evolving clinical needs.  Collectively, these strategies contribute to a competitive environment that is increasingly centered around technological differentiation and collaborative growth. In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several players vying for market share. This fragmentation is indicative of a landscape where innovation and strategic partnerships play a crucial role in shaping competitive dynamics. The collective influence of these key players fosters a competitive atmosphere that encourages continuous improvement and adaptation to market demands. In August 2025, Siemens Healthineers (DE) announced a strategic partnership with a leading healthcare provider to enhance the integration of AI in breast imaging. This collaboration aims to leverage AI algorithms to improve diagnostic accuracy and streamline workflows, thereby addressing the growing demand for efficient breast cancer screening solutions. The strategic importance of this partnership lies in its potential to set a new standard for diagnostic practices, positioning Siemens Healthineers as a leader in the integration of advanced technologies in breast ultrasound systems. In September 2025, Hologic (US) launched a new automated breast ultrasound system that incorporates [machine learning](https://www.marketresearchfuture.com/reports/machine-learning-market-2494) capabilities to enhance image analysis. This launch is significant as it reflects Hologic's commitment to innovation and its focus on improving patient outcomes through advanced technology. By integrating machine learning, Hologic aims to provide healthcare professionals with tools that facilitate more accurate diagnoses, thereby reinforcing its competitive edge in the market. In October 2025, GE Healthcare (US) unveiled a new initiative aimed at expanding its automated breast ultrasound offerings in emerging markets. This initiative is designed to address the growing need for accessible breast cancer screening solutions in regions with limited healthcare resources. The strategic importance of this move lies in GE Healthcare's ability to tap into new markets while simultaneously contributing to global health initiatives, thereby enhancing its brand reputation and market presence. As of October 2025, current competitive trends in the Automated Breast Ultrasound System Market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are increasingly shaping the landscape, as companies recognize the value of collaboration in driving innovation and enhancing product offerings. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological innovation, reliability in supply chains, and the ability to meet the diverse needs of healthcare providers and patients alike. .webp ## Recent News & Developments - **Q3 2025: In July 2025, GE HealthCare launched its Invenia ABUS 3.0 with enhanced AI lesion detection and faster scan times.** GE HealthCare introduced the Invenia ABUS 3.0 automated breast ultrasound system, featuring advanced AI for lesion detection and improved workflow efficiency, targeting supplemental screening for women with dense breast tissue. - **Q2 2025: In June 2025, Siemens Healthineers received CE Mark approval for its Acuson ABUS Elite system.** Siemens Healthineers secured CE Mark for its Acuson ABUS Elite, a 3D volumetric imaging system with automated positioning, enabling commercial rollout in European markets. ## Report Scope | MARKET SIZE 2024 | 3.458(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 3.675(USD Billion) | | MARKET SIZE 2035 | 6.758(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.28% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Hologic (US), Fujifilm (JP), Mindray (CN), Esaote (IT), Samsung Medison (KR) | | Segments Covered | Product Type, Application, End User, Technology, Regional | | Key Market Opportunities | Integration of artificial intelligence enhances diagnostic accuracy in the Automated Breast Ultrasound System Market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the Automated Breast Ultrasound System market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the projected market valuation of the Automated Breast Ultrasound System by 2035?** A: The market is projected to reach approximately 6.758 USD Billion by 2035. **Q: What was the market valuation of the Automated Breast Ultrasound System in 2024?** A: In 2024, the market valuation stood at 3.458 USD Billion. **Q: What is the expected CAGR for the Automated Breast Ultrasound System Market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during this period is 6.28%. **Q: Which companies are considered key players in the Automated Breast Ultrasound System Market?** A: Key players include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Hologic, among others. **Q: What are the projected revenues for the 2D Automated Breast Ultrasound System by 2035?** A: The 2D Automated Breast Ultrasound System is projected to generate revenues of approximately 2.9 USD Billion by 2035. **Q: How much revenue is expected from Breast Cancer Screening applications by 2035?** A: Breast Cancer Screening applications are expected to generate around 3.0 USD Billion by 2035. **Q: What is the anticipated revenue for Diagnostic Imaging Centers in the Automated Breast Ultrasound System Market by 2035?** A: Diagnostic Imaging Centers are projected to reach revenues of about 2.0 USD Billion by 2035. **Q: What revenue growth is expected for Shear Wave Elastography technology by 2035?** A: Shear Wave Elastography technology is expected to grow to approximately 1.5 USD Billion by 2035. **Q: What segment is expected to have the highest revenue growth in the Automated Breast Ultrasound System Market?** A: The Breast Cancer Screening segment is anticipated to exhibit the highest revenue growth by reaching 3.0 USD Billion by 2035. **Q: What was the revenue for Follow-up Imaging for Breast Cancer applications in 2024?** A: In 2024, the revenue for Follow-up Imaging for Breast Cancer applications was approximately 0.758 USD Billion. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/automated-breast-ultrasound-system-market-28877*